Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-07-23

FDA Approved: HYDROCHLOROTHIAZIDE — Original Application (ScieGen Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved the original application for Hydrochlorothiazide (ScieGen Pharmaceuticals, Inc.), a generic diuretic. It is indicated for hypertension and edema in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HYDROCHLOROTHIAZIDE (hydrochlorothiazide)

Snippet

ORIG AP for HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE)